Bronovo Hospital Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2005
NCT00250237
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

ciprofloxacin (cipro) (1 trial)

Drugs in Phase 3 Trials (1)

haloperidol (haldol) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 4)

Delirium (Phase 3)

Hip Fractures (Phase 3)

Infections (Phase 4)

Urinary Tract Infections (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2